Antiepileptic Drugs and Markers of Vascular Risk

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Treatment Options in Neurology

• Publication date

  2010-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11940-010-0080-yPMID 20842589PMCID PMC2941234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carotid wall thickness and stroke risk in patients with asymptomatic internal carotid stenosis.

  2010cited by this paper
• Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs

  2010cited by this paper
• The metabolic syndrome in overweight epileptic patients treated with valproic acid

  2010cited by this paper
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

  2009cited by this paper
• Effect of carbamazepine therapy on serum lipids in children with partial epilepsy.

  2009cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• Long‐term antiepileptic drug therapy contributes to the acceleration of atherosclerosis

  2009cited by this paper
• Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid.

  2009cited by this paper
• Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein

  2009cited by this paper
• Metabolic and Hormonal Disturbances in Women with Epilepsy on Antiepileptic Drug Monotherapy

  2007influential reference
• Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy.

  2007cited by this paper
• Carotid Intima-Media Thickening Indicates a Higher Vascular Risk Across a Wide Age Range: Prospective Data From the Carotid Atherosclerosis Progression Study (CAPS)

  2006cited by this paper
• Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital

  2006cited by this paper
• Effect of Antiepileptic Drugs on Plasma Lipids, Lipoprotein (a), and Liver Enzymes

  2006cited by this paper
• Short communication Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy

  2006cited by this paper
• Premature mortality in people with epilepsy in rural China: a prospective study.

  2006influential reference
• Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.

  2006cited by this paper
• Hyperhomocysteinemia in Children Treated with Antiepileptic Drugs Is Normalized by Folic Acid Supplementation

  2005cited by this paper
• Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy.

  2005cited by this paper
• Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes

  2004cited by this paper
• The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.

  2004cited by this paper
• The Epidemiology of the Comorbidity of Epilepsy in the General Population

  2004influential reference
• Fasting serum insulin and lipid levels in men with epilepsy

  2003cited by this paper
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

  2003cited by this paper
• Lipoprotein(a) Concentration Increases during Treatment with Carbamazepine

  2003cited by this paper
• Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid.

  2003cited by this paper
• Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland

  2002cited by this paper
• The role of cytochrome P450 in the regulation of cholesterol biosynthesis

  2002cited by this paper
• Antiepileptic drugs as independent predictors of plasma total homocysteine levels.

  2001cited by this paper
• Bodyweight Gain and Anticonvulsants

  2001cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children.

  2000cited by this paper
• Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients

  2000cited by this paper
• CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS

  2000cited by this paper
• The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.

  2000cited by this paper
• Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

  1999cited by this paper
• Serum lipids and lipoproteins in patients treated with antiepileptic drugs.

  1998cited by this paper
• Do Males 30–50 Years of Age with Chronic Epilepsy and on Long‐Term Anticonvulsant Medication Have Lower‐Than‐Expected Risk of Developing Coronary Heart Disease?

  1998cited by this paper
• Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants

  1997cited by this paper
• Cause‐Specific Mortality in Epilepsy: A Cohort Study of More Than 9,000 Patients Once Hospitalized for Epilepsy

  1997influential reference
• A prospective, randomized trial of phenytoin in nonepileptic subjects with reduced HDL cholesterol.

  1995cited by this paper
• Effects of long‐term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy

  1995cited by this paper
• Mortality from epilepsy: results from a prospective population-based study.

  1994influential reference
• Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine

  1994cited by this paper
• Serum lipid levels during carbamazepine medication. A prospective study.

  1993cited by this paper
• The Effect of Chronic Phenytoin Treatment on Serum Lipid Profile in Adult Epileptic Patients

  1992cited by this paper
• Total Cholesterol, High‐Density Lipoprotein Cholesterol, and Triglycerides in Children Receiving Antiepileptic Drugs

  1992cited by this paper
• Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital

  1991cited by this paper
• Case-control study of associated conditions at the time of death in patients with epilepsy.

  1988influential reference
• Effect of Anticonvulsant Drugs on Plasma Total Cholesterol, High-Density Lipoprotein Cholesterol, and Apolipoproteins A and B in Children with Epilepsy

  1985cited by this paper
• Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.

  1985cited by this paper
• Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy.

  1985cited by this paper
• Heart Disease Mortality and Morbidity in Patients with Epilepsy

  1984cited by this paper
• Inhibition of cholesterol synthesis by oxygenated sterols

  1978cited by this paper

• Analysis of ASMs and male infertility using the FDA adverse event reporting system (FAERS)

  2026cites this paper
• Epileptic seizures in patients with stroke

  2026cites this paper
• Fenfluramine and Comparative Antiseizure Therapies in Drug-Resistant Epilepsy: A Systematic Review of Efficacy, Cardiometabolic Safety, and Clinical Outcomes

  2025cites this paper
• Role of different anti-seizure medications on carotid intima–media thickness: A systematic review and meta-analysis

  2025cites this paper
• Antiseizure medications and their differing effects on cardiovascular risk

  2025cites this paper
• Cardiovascular Effects of Antiseizure Medications for Epilepsy

  2025cites this paper
• Anfallssuppressive medikamentöse Langzeittherapie: Problemerkennung und Problembeseitigung

  2025cites this paper
• The effect of anticonvulsant drugs on serum lipid profile

  2024cites this paper
• Is there any concern of insulin resistance and metabolic dysfunctions with antiseizure medications? A prospective comparative study of valproate vs. levetiracetam.

  2024cites this paper
• Kardiovaskularni čimbenici rizika u bolesnika s teškim duševnim bolestima

  2024cites this paper
• Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy.

  2024cites this paper
• The therapeutic effects of lacosamide on epilepsy-associated comorbidities

  2023cites this paper
• Increased vascular risk factors, atherosclerosis, and psychological distress among Indian adults with refractory epilepsy in comparison to well-controlled epilepsy.

  2023cites this paper
• Comparison of myocardial perfusion between the users of two antiepileptic medications: valproate vs. carbamazepine

  2023influential citation
• Epilepsy Treatment in Patients with Heart Disease

  2023cites this paper
• Topiramate treatment during the peripubertal period does not alter aortic endothelial function in female Wistar rats.

  2023cites this paper
• Assessment of Topiramate VS Valproate Effects on Serum Lipid Profile in Young Adults with Epilepsy : A Retrospective Study

  2023cites this paper
• Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

  2023cites this paper
• Effects of Carbamazepine on blood pressure, serum glucose concentration, lipid profile and prevalence of metabolic syndrome in epileptic patients

  2023cites this paper
• Application Value of Serum Metabolic Markers for Cognitive Prediction in Elderly Epilepsy

  2022cites this paper
• Metabolic syndrome and its associated factors among epileptic patients at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia; a hospital-based comparative cross-sectional study

  2022cites this paper
• Long-Term Effects of Antiseizure Medications

  2022cites this paper
• Accident vasculaire cérébral et psychiatrie

  2022cites this paper
• Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: A longitudinal cohort study.

  2022cites this paper
• Complications associated with the use of enzyme-inducing and non-enzyme-inducing anti-seizure medications in the Japanese population: A retrospective cohort study.

  2022cites this paper
• Quinazoline: An update on current status against convulsions

  2022cites this paper
• You Snooze You Seize: GABAergic Potentiation of Genetic Generalized Seizures During NREM

  2021cites this paper
• The Search for Autoimmune-Associated Epilepsy Continues—Are We Getting Closer to Our Target?

  2021cites this paper
• Equity and the JAMA Network.

  2021cites this paper
• Wheels Within Wheels: Theory and Practice of Epileptic Networks

  2021cites this paper
• Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities

  2021cites this paper
• Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management

  2021cites this paper
• Treatment of Super-Refractory Status Epilepticus: A Review

  2021cites this paper
• How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries

  2021cites this paper
• Impact of carbamazepine on vitamin D levels: A meta-analysis.

  2021cites this paper
• A potentiometric biosensor for the determination of valproic acid: Human blood–based study of an anti–epileptic drug

  2021cites this paper
• Association of Enzyme-Inducing Antiseizure Drug Use With Long-term Cardiovascular Disease.

  2021cites this paper
• Metabolic Effects of Anti-Seizure Medications: A Time to Reevaluate Risks?

  2021cites this paper
• Like Mother, Like Child. Keeping Control of Seizures During Pregnancy

  2021cites this paper
• To Stop the Seizure, You Must Become the Seizure: Closed-Loop Stimulation Phase Locked to Seizure Waves Disrupts Kindled Seizures While Open-Loop Stimulation Fails

  2021cites this paper
• Staving Off the Heat With Microglia

  2021cites this paper
• Breaking the Seizure Randomness Myth: Evidence for a Recurring Ebb and Flow of Seizure Risk on the Continuum of Time

  2021cites this paper
• Predicting the risk of stroke in patients with late-onset epilepsy: A machine learning approach.

  2021cites this paper
• Pregnancy Effects on Seizure Frequency: To Seize or Not to Seize

  2021cites this paper
• Progress Toward Obtaining Seizure Freedom With New Medications in Older Adults

  2021cites this paper
• Perineuronal Net Dynamics in the Pathophysiology of Epilepsy

  2021cites this paper
• Are We Inviting Another Attendee to the Temporal Lobe Epilepsy Party?

  2021cites this paper
• Disentangling the Gordian Knot of Drug-Resistant Epilepsy

  2021cites this paper
• Epileptic heart: A clinical syndromic approach

  2021cites this paper
• Effect of acute and chronic exposure to lovastatin on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

  2021cites this paper
• The Molecular Dichotomy Between Epileptic and Functional Seizures

  2021cites this paper
• COVID-19 Incidence and Death Rate in Epilepsy: Too Early to Tell?

  2021cites this paper
• Treating Post-Traumatic Seizures to Limit Tau Accumulation in Larval Zebrafish

  2021cites this paper
• Localizing the Seizure Onset Site Through Metabolic Imaging of GABA

  2021cites this paper
• The Course of Inhibition Never Did Run Smooth: Parvalbumin Interneuron Dysfunction in a Mouse Model of Lissencephaly

  2021cites this paper
• Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events

  2021cites this paper
• Highlights From AES2020, a Virtual American Epilepsy Society Experience

  2021cites this paper
• Modifiable Risk Factors of Dementia in Older Adults With Epilepsy: An Opportunity to Flatten the Curve?

  2021cites this paper
• Stimulating Solutions for Intractable Epilepsy

  2021cites this paper
• Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking.

  2020cites this paper
• Enzyme-inducing antiseizure medication utilization in patients with epilepsy and vascular risk factors.

  2020cites this paper
• Hyperlipidemia in patients newly treated with anticonvulsants: A population study

  2020cites this paper
• The Impact of Antiepileptic Drugs on Thyroid Function in Children with Epilepsy: New Versus Old

  2020cites this paper
• Management of antiepileptic drug–induced nutrition-related adverse effects

  2020cites this paper
• Epilepsy and Cardiovascular Function

  2020cites this paper
• Increased risk of stroke and myocardial infarction in patients with epilepsy: A systematic review of population-based cohort studies.

  2020cites this paper
• Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy.

  2020cites this paper
• A review on the synthesis and applications of molecules as anticonvulsant drug agent candidates

  2020cites this paper
• EFFECT OF PROGRESSIVE ABSENCE EPILEPSY AND ITS TREATMENT ON HEMODYNAMICS AND AUTONOMIC REGULATION OF THE HEART RHYTHM

  2019cites this paper
• Epilepsy and heart diseases

  2019cites this paper
• The Correlation between Old-Generation Antiepileptic Drugs Usage with Carotid Intima-Media Thickness in Epilepsy Patient

  2019cites this paper
• Concentrations of the Selected Biomarkers of Endothelial Dysfunction in Response to Antiepileptic Drugs: A Literature Review

  2019cites this paper
• Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy.

  2019cites this paper
• Epilepsy and aging.

  2019cites this paper
• Mood stabilisers and risk of stroke in bipolar disorder

  2018cites this paper
• Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs.

  2018influential citation
• Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.

  2018cites this paper
• Effect of Carbamazepine on Serum Cholesterol and Atherogenic Ratios in Young Adults with Epilepsy

  2018cites this paper
• Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid‐lowering agents in the elderly

  2018cites this paper
• Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.

  2017cites this paper
• ASSESSMENT OF POTENTIAL EFFECT OF ANTIEPILPETIC DRUGS ON LIPID PROFILE AND C-REACTIVE PROTEIN AS PREDICTORS OF VASCULAR DISEASE IN EPILEPSY PATIENTS

  2017cites this paper
• PREVENTION OF EPILEPSY BY LOW-DOSE ARTESUNATE + ESOMEPRAZOLE-FUROSEMIDE SEQUENTIAL THERAPY.

  2017cites this paper
• The heart of epilepsy: Current views and future concepts.

  2017cites this paper
• Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy.

  2017cites this paper
• Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study

  2017cites this paper
• Late-onset seizures: a subclinical cerebrovascular disorder?

  2017cites this paper
• Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment

  2017cites this paper
• Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study

  2016cites this paper
• Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids

  2016cites this paper
• The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications

  2016cites this paper
• Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.

  2016cites this paper
• Cognitive deterioration in adult epilepsy: Does accelerated cognitive ageing exist?

  2016cites this paper
• Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients.

  2016cites this paper
• Somatic co‐morbidities in epilepsy

  2015cites this paper
• Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study

  2015cites this paper
• Evaluation of penile vascular status in men with epilepsy with erectile dysfunction.

  2015cites this paper
• A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis

  2015cites this paper
• Long Term Somatic Adverse Events of Antiepileptic Drugs Les effets secondaires à long terme des médica-ments antiépileptiques

  2015cites this paper
• Serum Lipids and Thyroid Functions in Young Epileptic Patients Undergoing Monotherapy with Valproate or Levetiracetam

  2015cites this paper
• Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review.

  2015cites this paper